Environmental Cardiopulmonary Disease Group
The Environmental Cardiopulmonary Disease Group conducts research on exposure assessment and prevention of asthma within the Immunity, Inflammation, and Disease Laboratory. For more information, please see the links to individual project pages.
- COX-Derived Eicosanoids are important modulators of the lung immune response to environmental agents.
- Cytochromes P450 and the Bioactivation of Arachidonic Acid details the opportunities for translational research including development of novel therapeutics for blood pressure control, vascular inflammation, atherosclerosis and ischemic heart disease.
- Asthma, Allergy, and the Environment examines indoor allergen and bacterial lipopolysaccharide exposures, which are important asthma risk factors.